Clinical Study
Nitroglycerin for Management of Retained Placenta: A Multicenter Study
Table 3
Clinical data for management of retained placenta by treatment group (per protocol population, PP).
| | Variable | Nitroglycerin () | Placebo () | -value | Relative Risk (RR) 95% CI |
| | Placental detachment | | | | | | | 19 (37.3) | 11 (20.4) | 0.056 | 1.83 (0.97; 3.46) |
| | Blood loss after treatment (mL) | | | | | | Mean (SD) | 474 (470) | 569 (468) |
0.31 | | | Median (range) | 250.0 (50; 2200) | 400 (0; 1800) | |
| | Total blood loss (mL) | | | | | | Mean (SD) | 1020 (604) | 1091 (662) |
0.58 | | | Median (range) | 925 (200; 2500) | 950 (150; 3000) | |
| | Total blood loss ≥1000 mL | | | | | | | 23 (45.1) | 25 (46.3) | 0.90 | 0.97 (0.64; 1.48) |
|
|
Per protocol population (PP): randomized patients who all received 1 mg nitroglycerin or placebo tablets.
|
